Showing results (2621-2630 of 13,599) with videos related to
Sort By:
Pageof 1,360
Atherosclerosis|December 2, 2017
Brachial artery diameter as a marker for cardiovascular risk assessment: FMD-J studyTatsuya Maruhashi, Junko Soga, Noritaka Fujimura, et al.Atherosclerosis|September 3, 2017
Hydrogen sulfide attenuates calcification of vascular smooth muscle cells via KEAP1/NRF2/NQO1 activationParisa Aghagolzadeh, Ramin Radpour, Matthias Bachtler, et al.Atherosclerosis|September 3, 2017
Increased diabetes risk and interaction with social and medical events in patients upon stroke: Two nationwide studiesLu-Min Chu, Chih-Chung Liu, Chun-Chieh Yeh, et al.Atherosclerosis|October 17, 2017
Opposing effects of rheumatoid arthritis and low dose prednisolone on arginine metabolomicsAnjana Radhakutty, Brenda L Mangelsdorf, Sophie M Drake, et al.Atherosclerosis|September 26, 2017
Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) studyNina Schmidt, Burkhard Schmidt, Alexander Dressel, et al.Atherosclerosis|September 26, 2017
ABCA1 and HDL3 are required to modulate smooth muscle cells phenotypic switch after cholesterol loadingSilvia Castiglioni, Matteo Monti, Lorenzo Arnaboldi, et al.Atherosclerosis|September 27, 2017
Leukocyte telomere length and cardiovascular disease in African Americans: The Jackson Heart StudyStanford Mwasongwe, Yan Gao, Michael Griswold, et al.Atherosclerosis|September 20, 2017
Low dose of alcohol attenuates pro-atherosclerotic activity of thrombinMasaaki Toda, Toshiaki Totoki, Chizu Nakamura, et al.Atherosclerosis|October 13, 2017
Environmental tobacco smoke and peripheral arterial disease: A reviewNatalie Ly Ngu, Mark McEvoyAtherosclerosis|June 25, 2016
Aspirin and cardiovascular primary prevention in non-endstage chronic kidney disease: A meta-analysisRupert W Major, Issaam Oozeerally, Simon Dawson, et al.Pageof 1,360